everytraceeverytraceeverytraceeverytrace
all names

Christopher Oreilly person

Named in 1 report across 1 story - 22 Sept

The web around Christopher Oreilly

Closest companions, sized by how often they share a report with Christopher Oreilly. Lines between the outer names are their own relationships - names that appear together even without Christopher Oreilly.

Access Program and China share 1 reportDocetaxel Monotherapy and Madrid share 1 reportArcotatug Tavatecan and International Normalized Ratio share 1 reportEuropean Society For Medical Oncology and Exchange Commission share 1 reportAccess Program and Madrid share 1 reportAccess Program and European Society For Medical Oncology share 1 reportExchange Commission and International Normalized Ratio share 1 reportChina and International Normalized Ratio share 1 reportEuropean Society For Medical Oncology and Japanese share 1 reportArcotatug Tavatecan and Madrid share 1 reportArcotatug Tavatecan and Japanese share 1 reportAccess Program and Japan share 1 reportJapan and Japanese share 1 reportInternational Normalized Ratio and Japan share 1 reportJapan and Madrid share 1 reportInternational Normalized Ratio and Madrid share 1 reportJapanese and Madrid share 1 reportDocetaxel Monotherapy and International Normalized Ratio share 1 reportAccess Program and International Normalized Ratio share 1 reportArcotatug Tavatecan and European Society For Medical Oncology share 1 reportEuropean Society For Medical Oncology and Madrid share 1 reportAccess Program and Japanese share 1 reportExchange Commission and Madrid share 1 reportChina and Exchange Commission share 1 reportChina and Madrid share 1 reportChina and Japanese share 1 reportInternational Normalized Ratio and Japanese share 1 reportEuropean Society For Medical Oncology and Japan share 1 reportChina and Japan share 1 reportDocetaxel Monotherapy and Japan share 1 reportDocetaxel Monotherapy and Exchange Commission share 1 reportDocetaxel Monotherapy and European Society For Medical Oncology share 1 reportArcotatug Tavatecan and Docetaxel Monotherapy share 1 reportExchange Commission and Japan share 1 reportEuropean Society For Medical Oncology and International Normalized Ratio share 1 reportArcotatug Tavatecan and Japan share 1 reportArcotatug Tavatecan and Exchange Commission share 1 reportChina and European Society For Medical Oncology share 1 reportAccess Program and Arcotatug Tavatecan share 1 reportDocetaxel Monotherapy and Japanese share 1 reportChristopher OreillyAccess ProgramAccess Program - 1 shared report (organization)Arcotatug T…Arcotatug Tavatecan - 1 shared report (person)ChinaChina - 1 shared report (place)Docetaxel M…Docetaxel Monotherapy - 1 shared report (person)European So…European Society For Medical Oncology - 1 shared report (organization)Exchange Commissi…Exchange Commission - 1 shared report (organization)Internation…International Normalized Ratio - 1 shared report (organization)JapanJapan - 1 shared report (place)JapaneseJapanese - 1 shared report (place)MadridMadrid - 1 shared report (place)

The stories

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026

60 outlets1 report names Christopher Oreilly5 Aug – 22 Oct

People they appear with

Arcotatug Tavatecan1Docetaxel Monotherapy1Phuong Khanh1Tsuyoshi Tada1

Places in the same coverage

China1Japan1Japanese1Madrid1Osaka1Spain1

Organisations in the same coverage

Access Program1European Society For Medical Oncology1Exchange Commission1International Normalized Ratio1Takeda Pharmaceutical Company Limited Takeda1Takeda Pharmaceuticals1

Who keeps naming them

intelligencer.ca1

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.